Characterization of a mouse model of hyperglycemia and retinal neovascularization

American Journal of Pathology

Volumn 177, Issue 5, 2010, Pages 2659-2670

  Rakoczy, Elizabeth P ^a,b   Ali Rahman, Ireni S ^a   Binz, Nicolette ^b   Li, Cai Rui ^a,c   Vagaja, Nermina N ^a   De Pinho, Marisa ^b   Lai, Chooi May ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

^c DALI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMETRY; CONTROLLED STUDY; DIABETIC RETINOPATHY; EDEMA; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN INTERACTION; RETINA ANGIOGRAPHY; RETINA NEOVASCULARIZATION; STRAIN DIFFERENCE; VASCULAR DISEASE;

EID: 78149352178     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090883     Document Type: Article

References (50)

1. Hogan P, Dall T, Nikolov P: Economic costs of diabetes in the US in 2002. Diabetes Care 2003, 26:917-932
2. Izumi T, Yokota-Hashimoto H, Zhao S, Wang J, Halban PA, Takeuchi T: Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes 2003, 52:409-416
3. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002, 109:525-532
4. Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, Lu D, Takata K, Koizumi A, Izumi T: A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 1999, 103:27-37
5. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK: The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005, 46:2210-2218
6. Conaway HH, Brown CJ, Sanders LL, Cernosek SF, Farris HE, Roth SI: Spontaneous diabetes mellitus in the New Zealand white rabbit: history, classification, and genetic analysis. J Hered 1980, 71:179-186
7. Gerritsen GC, Dulin WE: Characterization of diabetes in the Chinese hamster. Diabetologia 1967, 3:74-84
8. Kramer JW, Nottingham S, Robinette J, Lenz G, Sylvester S, Dessouky MI: Inherited, early onset, insulin-requiring diabetes mellitus of Keeshond dogs. Diabetes 1980, 29:558-565
9. Lenzen S, Tiedge M, Elsner M, Lortz S, Weiss H, Jorns A, Kloppel G, Wedekind D, Prokop CM, Hedrich HJ: The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia 2001, 44:1189-1196
10. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y: Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980, 29:1-13
11. Nakhooda AF, Like AA, Chappel CI, Murray FT, Marliss EB: The spontaneously diabetic Wistar rat: metabolic and morphologic studies. Diabetes 1977, 26:100-112
12. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ: Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 2008, 49:2635-2642
13. Lai CM, Shen WY, Brankov M, Lai YK, Barnett NL, Lee SY, Yeo IY, Mathur R, Ho JE, Pineda P, Barathi A, Ang CL, Constable IJ, Rakoczy EP: Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther 2005, 12:659-668
14. van Eeden PE, Tee LB, Lukehurst S, Lai CM, Rakoczy EP, Beazley LD, Dunlop SA: Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 2006, 47:4638-4645
15. Shen WY, Lai CM, Graham CE, Binz N, Lai YK, Eade J, Guidolin D, Ribatti D, Dunlop SA, Rakoczy PE: Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia 2006, 49:1690-1701
16. Campochiaro PA: Retinal and choroidal neovascularization. J Cell Physiol 2000, 184:301-310
17. Lai CM, Dunlop SA, May LA, Gorbatov M, Brankov M, Shen WY, Binz N, Lai YK, Graham CE, Barry CJ, Constable IJ, Beazley LD, Rakoczy EP: Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol 2005, 89:911-916
18. Lai CM, Estcourt MJ, Wikstrom ME, Himbeck RP, Barnett NL, Brankov M, Tee LB, Dunlop SA, Degli-Esposti MA, Rakoczy EP: rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector. Invest Ophthalmol Vis Sci 2009, 50:4279-4287
19. Shen WY, Lai CM, Lai YK, Zhang D, Zaknich T, Sutanto EN, Constable IJ, Rakoczy PE: Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations. J Gene Med 2003, 5:576-587
20. Han BG, Hao CM, Tchekneva EE, Wang YY, Lee CA, Ebrahim B, Harris RC, Kern TS, Wasserman DH, Breyer MD, Qi Z: Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. Am J Physiol Endocrinol Metab 2008, 295:E981-E986
21. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP: VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003, 44:2155-2162
22. Verley FA, Grahn D, Leslie WP, Hamilton KF: Sex ratio of mice as possible indicator of mutation rate for sex-linked lethals. J Hered 1967, 58:285-290
23. Biallosterski C, van Velthoven ME, Michels RP, Schlingemann RO, DeVries JH, Verbraak FD: Decreased optical coherence tomographymeasured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. Br J Ophthalmol 2007, 91:1135-1138
24. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci 1981, 21:1-226
25. Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H: Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy. Ophthalmology 2008, 115:1916-1922
26. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998, 111:1-6
27. Lu M, Perez VL, Ma N, Miyamoto K, Peng HB, Liao JK, Adamis AP: VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 1999, 40:1808-1812
28. Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP: Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999, 96:10836-10841
29. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996, 103:1820-1828
30. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA: Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997, 151:281-291
31. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA: Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 2001, 188:253-263
32. Ferris FL 3rd, Patz A: Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 1984, 28(Suppl):452-461
33. Feng Y, Wang Y, Pfister F, Hillebrands JL, Deutsch U, Hammes HP: Decreased hypoxia-induced neovascularization in angiopoietin-2 heterozygous knockout mouse through reduced MMP activity. Cell Physiol Biochem 2009, 23:277-284
34. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honore JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beausejour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S: The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008, 14:1067-1076
35. Asefzadeh B, Fisch BM, Parenteau CE, Cavallerano AA: Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clin Experiment Ophthalmol 2008, 36:455-463
36. Shimada Y, Li Y, Bearse MA Jr, Sutter EE, Fung W: Assessment of early retinal changes in diabetes using a new multifocal ERG protocol. Br J Ophthalmol 2001, 85:414-419
37. Gora-Kupilas K, Josko J: The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 2005, 43:31-39
38. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM: Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 2006, 26:12439-12446
39. Adamis AP: Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002, 86:363-365
40. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997, 38:36-47
41. Boulton M, Foreman D, Williams G, McLeod D: VEGF localisation in diabetic retinopathy. Br J Ophthalmol 1998, 82:561-568
42. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996, 114:971-977 (Pubitemid 26271463)
43. Malecaze F, Clamens S, Simorre-Pinatel V, Mathis A, Chollet P, Favard C, Bayard F, Plouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994, 112:1476-1482
44. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E: Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996, 80:241-245
45. Shen WY, Yu MJ, Barry CJ, Constable IJ, Rakoczy PE: Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 1998, 82:1063-1071
46. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H: Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 1995, 27:48-52
47. Knol JA, van Kooij B, de Valk HW, Rothova A: Rapid progression of diabetic retinopathy in eyes with posterior uveitis. Am J Ophthalmol 2006, 141:409-412
48. Perry VH: A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 1998, 90:113-121
49. Penfold PL, Liew SC, Madigan MC, Provis JM: Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci 1997, 38:2125-2133
50. Xu H, Dawson R, Forrester JV, Liversidge J: Identification of novel dendritic cell populations in normal mouse retina. Invest Ophthalmol Vis Sci 2007, 48:1701-1710